Waste Management Reports 19% Q2 Growth

Waste Management (WM) reported a strong Q2 2025, surpassing expectations with non-GAAP EPS of $1.92 and GAAP revenue of $6.43 billion, marking a 19.0% year-over-year increase primarily driven by its renewable energy and healthcare segments. The company demonstrated robust operational efficiency, achieving a record low operating expense margin, and generated significant free cash flow, leading to a raised annual free cash flow guidance for fiscal 2025 and a 10% dividend increase. While the full-year revenue outlook was slightly trimmed due to soft recycling commodity prices and share buybacks are paused to manage leverage, WM continues to advance its sustainability initiatives and integrate strategic acquisitions like Stericycle.

Analysis

Waste Management (WM) reported a strong second quarter for 2025, exceeding consensus estimates with a non-GAAP EPS of $1.92 and GAAP revenue of $6.43 billion. The 19.0% year-over-year revenue growth was substantially driven by the integration of its Healthcare Solutions segment and expansion in renewable energy, demonstrating successful strategic diversification. Operationally, the company achieved a record low operating expense margin of 59.4%, indicating significant efficiency gains, while the core collection and disposal segment's adjusted EBITDA margin expanded by 1.3 percentage points to 31.3%. This operational strength translated into robust free cash flow, which surged 54.3% to $818 million, prompting management to raise its full-year free cash flow guidance to $2.8–$2.9 billion. Despite these positives, headwinds persist, including a decline in average recycling commodity prices to $82 per ton, which led to a trimmed full-year revenue outlook. On the capital allocation front, the company increased its dividend by 10% but has paused share buybacks to manage leverage following the Stericycle acquisition, a prudent but temporary removal of a shareholder return mechanism.

Key Decisions for Investors

• Investors should view the strong free cash flow generation and raised annual guidance as a key positive, reinforcing the company's operational strength and ability to support its 22nd consecutive annual dividend increase.
• Monitor the integration of the Healthcare Solutions segment closely, as achieving the targeted $80-$100 million in fiscal 2025 synergies is crucial for validating the acquisition's value proposition and improving segment margins.
• While the core business remains robust, be mindful of the trimmed revenue outlook, which reflects ongoing volatility in recycling commodity prices and could present a persistent headwind to top-line growth.
• The temporary pause on share buybacks to deleverage the balance sheet is a short-term constraint on capital returns; the resumption of buybacks would signal that management is comfortable with its leverage ratios and could act as a future positive catalyst for the stock.